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SUMMARY
Purpose. The aim of this study was to evaluate early morphofunctional response of contact
tissue to pure and saturated with lidocaine porous synthetic HAp ceramic implants inserted in holes
of rabbit upper jaw.
Materials and Methods. Pure and saturated with lidocaine cylinders of porous HAp ceramics
produced at Biomaterials R&D Laboratory of Riga Technical University were inserted into edentu-
lous part of the upper jaw of 12 New Zealand male rabbits. After two weeks, blocks of soft tissue
and bone were taken out. The sections done with EXACT Grunding system and from paraffin
blocks were stained with haematoxylin/eosin and by use of biotin-streptavidin immunohistochemistry
for transforming growth factor β1 (TGFβ1), fibroblast growth factor receptor 1 (FGFR1), interleukin
10 (IL10). Apoptosis was detected by TUNEL method.
Results. TGFβ1 was equally expressed in the bone around HAp implants saturated with lidocaine
and without lidocaine, while control sections did not show any expression of TGFβ. In contacting
bone tissue to pure HAp and HAp saturated with lidocaine as well in controls rich expression of
FGFR1 was observed. In soft tissue of experimental samples also rich expression of FGFR1 was
observed, although it was weak in control samples. IL10 had rich expression in all samples. The
mean number of apoptotic cells was higher in samples with pure HAp, slightly decreased in samples
HAp with lidocaine and significantly lower in controls.
Conclusions. The expression of TGF β1 confirms osteoinductive activity of HAp. Contact soft
tissue to HAp showed rich FGFR1 expression, and weak in controls suggesting higher plasticity of
connective tissue to implants in comparison with supportive tissue.
Slightly lower apoptosis in samples of HAp with lidocaine gives evidence of indistinct influence
of saturated with lidocaine HAp implants on development of programmed cell death.
Key words: implantation of hydroxyapatite in bone, lidocaine, transforming growth factor β,
fibroblast growth factor receptor, interleukin 10, apoptosis.
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INTRODUCTION
Augmentation of various congenital and acquired
defects of bone tissue is a topical problem in oral
and maxillofacial surgery. Around half of the pa-
tients requiring dental implants has severe alveolar
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bone deficit which can be replaced using bone graft-
ing from the patient, biomaterials or combination of
both.  Autografts usually imply additional operation
with donor site morbidity and unpredictable graft
resorbtion in a long term. The aim of reconstruction
of soft and hard tissues is to achieve optimal func-
tional stability and good aesthetic result [1].
Early stages in osseointegration of bone substi-
tutes run in a close interaction of inflammatory and
regenerative processes. Biomaterials of different ori-
gins as natural and synthetic ones have different
mechanisms of host response. Biomaterials should
be stable, biocompatible, ideally osseoinductive and
conductive, porous and similar to biological bone
mechanically [2]. Synthetic HAp is artificially cre-
ated main mineral constituent of bone and as such
it has no biological ingredients possible to initiate
immunological response. Calcium phosphate ceramics
and bioactive glass started to be used for bone sub-
stitution 30 years ago. These materials are consid-
ered bioactive because they join with bone and
enhance bone regeneration [2].
Besides the main aim of bioceramic as bone
substitutes seeding of biomaterials with drugs in
order to diminish inflammatory response may be
important for improvement of postoperative care
and decrease a need of anti-inflammatory and an-
algesic drugs. The local use of drugs may reduce
dosage and side effects and provide higher concen-
tration in the area of surgical intervention [3].
HAp saturated with local anaesthetic lidocaine
may diminish pain and inflammation in the early
postoperative period.
The objective of this study was evaluation of
early morphofunctional response of contact tissue
to pure and saturated with lidocaine porous syn-




Porous hydroxyapatite (HAp) ceramics were
obtained from HAp powder  synthesized at
Fig. 3. Bone and connective tissue around pure  Hap im-
plant inside jaw bone. Haem/ eos, x200.
Fig. 4. More connective tissue around  HAp implant satu-
rated with lidocaine. Haem/eos, x200.
Fig. 1. Light microscopy of HAp ceramic surface Fig. 2. Scanning electronmicroscopy of HAp ceramic
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Biomaterials R&D Laboratory of Riga Technical
University using wet chemical method from Ca(OH)2
and H3PO4 solutions and calcinated at 800 ºC. To
form green bodies, HAp powder was mixed with
paraffin wax and gelatin (70:25:5) and uniaxially
pressed in a form of a cylinder (1.8 mm diameter,
4 mm length). The green bodies were sintered at
1100ºC. The porosity of obtained ceramics was 25-
30%, water uptake 10-13% from mass and volume
mass 2.1-2.2 g/cm3 (Figures 1, 2).
Synthetic HAp ceramic cylinders were satu-
rated with Sol. Lidocaini hydrochloridi 2% using
vacuum extraction method. Every HAp ceramic
cylinder contains 1.6 mg of Lidocaini hydrochloridi.
Implantation of HAp cylinders in rabbit up-
per jaw
With permission of the Animal Ethics Commit-
tee of Latvian Food and Veterinary Administration
experimental operations on 14 New Zealand male
rabbits (weight 3.5 kg) were done (Table). Local
anaesthesia with Sol. Lidocaini 2% (4 mg/kg) as
well general anaesthesia with Ketamin 15 mg/kg
and Midazolam 0.5 mg/kg was performed.
After rising of mucoperiostal flap in edentulous
part of the right upper jaw a hole of 2.0 mm diam-
eter was drilled, HAp cylinder of 1.8 mm diameter
with lidocaine or without lidocaine was inserted and
the wound was closed in two layers. On the left
side the same operation without insertion of HAp
implants was done.
Histological and immunohistochemical evalu-
ation
After two weeks euthanasia by air embolisation
was performed. The blocks of soft tissue and bone
were taken out, and fixed in Stefanini solution. Sec-
tions done with EXACT Grunding system and from
paraffin blocks were stained with haematoxylin/eosin
for review of the picture and using biotin and
streptavidin immunohistochemical methods [Hsu et
al., 1981]. The samples of bone and contacting soft
tissue were prepared and evaluated regarding ex-
pression of  transforming growth factor  β1 (TGFβ1,
1279, 1:1000, Cambridge Science Park, UK) and
fibroblast growth factor receptor 1 (FGFR1, 10646,
1:100, Cambridge Science Park, UK). Evaluation of
interleukin 10 (IL10, code ab34843, 1:400, Abcam,
UK) was also performed in soft tissue.  TUNEL
method was used for evaluation of apoptosis in con-




On histological slices stained with haematoxylin/
eosin in gingival tissue around pure HAp ceramic
implants a capsule of connective tissue and degen-
erative epitheliocytes without inflammation have
formed. Analyzing bone tissues after pure HAp
implantation, we observed uneven bone trabeculas
with few osteones and soft tissues have ingrown in
bone channels (Figure 3).  After implantation of
HAp with lidocaine we found massive proliferation
of connective tissue between bone fragments (Fig-
ure 4).
Immunohistochemistry
In bone tissue there was rich expression of
FGFR1 in experimental side (HAp  and HAp with
Table. Design of experiment
Implant type and site No of animals 
Intraosal implantation of pure HAp ceramic 
in upper jaw 
6 rabbits 
Intraosal implantation of HAp ceramic with 
lidocaine in upper jaw  
6 rabbits 
Control – identical operation, without  HAp  
ceramic implantation  
2 rabbits 
 
Fig. 5. Rich expression of FGFR1 in connective tissue after
HAp implantation. IMH, FGFR1, x200.
Fig. 6. Expression of FGFR1 in control tissue. IMH, FGFR1,
x200.
116 Stomatologija, Baltic Dental and Maxillofacial Journal, 2009, Vol. 11, No. 4
I. Salma et al. SCIENTIFIC ARTICLES
lidocaine)  and in control side. TGFβ was inten-
sively expressed in cells of endosteum and bone
around pure HAp implants, but it had moderate
expression in bone and intensive expression in en-
dosteum with HAp with lidocaine. On the control
side only endosteum was TGFß positive, while os-
teocytes were factor negative.
Connective tissue structures possess rich
FGFR1 expression around HAp implants with
lidocaine and without lidocaine (Figure 5), while
control tissue demonstrated only few cells positive
for FGFR1 (Figure 6).
Apoptosis
The mean number of apoptotic cells was higher
after pure HAp ceramic implantation – 54.2 in com-
parison with HAp ceramic with lidocaine – 45.2,
but in control tissue the mean value of apoptotic
cells was 23.9 (Figure 7).
DISCUSSION
In our experiment, the contact soft tissue re-
sponse to implantation of pure HAp and HAp cyl-
inders with lidocaine regarding the type and activity
of inflammation was similar with normal wound
healing of the same bone in the same part. A thin
capsule of connective tissue appeared around HAp
ceramic without signs of inflammation. Inflamma-
tion and foreign body reaction are common threads
in all implanted synthetic materials. Optimum soft-
tissue biocompatibility, characterized either by thin
fibrous encapsulation or by mesenchymal ingrowth
into pores, is achieved by avoiding the body’s natu-
ral response to an implanted foreign body [7]. Non-
specific reactogenicity which becomes apparent
mainly through influence on in-
flammation and its after effects
usually on histological level has
compared with morphology of
wound healing of the same tis-
sue in the same topographic
anatomy relations as on opera-
tion with implant insertion [8].
Rucker [9] reports results after
synthetic hydroxyapatite implan-
tations into the dorsal skin fold
chamber of mice. After 14 day
period implantation of HAp
causes slight increase in leuko-
cyte recruitment compared with
the control. In our experiment
the lack of remarkable inflam-
mation was also confirmed by
moderate expression of IL10,
cells immunohistochemical marker of inflammation
that did not differ from the control group.
 TGF β1 was expressed at higher levels dur-
ing chondrogenesis and osteogenesis during nor-
mal fracture healing of the rat femur [10]. Langdahl
[11] reported that TGF β1 is produced by osteo-
blasts and it inhibits osteoclast proliferation and
activity and stimulates proliferation and differen-
tiation of preosteoblasts. Data from numerous in
vitro experiments have demonstrated conflicting
results regarding the role of TGF β1 in bone for-
mation. Most data support the opinion that TGF β1
stimulates the proliferation of osteoblasts, as well
promotes the early stages of differentiation and
bone matrix production. On the other hand, it blocks
later phases of differentiation and mineralization
[12]. In vivo situation, in which osteoblasts are
found in tight clusters, corresponds best to a
confluent culture; TGF β1 stimulates osteoblast pro-
liferation [13]. In vivo, the presence of other
growth factors in the bone environment and envi-
ronment as such determine the exact outcome of
TGF β1 functioning. In our results positive expres-
sion of TGF β1 in contact bone tissue may con-
firm osteoinductive activity of HAp.
Hughes and Hall [14] reported that FGF-1 and
FGF-2 are widely expressed in normal adult tis-
sue, as well as FGFR-1, FGFR-2 and FGFR-3.
FGF-1 and FGF-2 and their receptors have been
implicated in a wide range of normal physiological
processes in vivo and in various disease states,
including cer tain forms of neoplasia  and
neurodegenerative disorders [14]. The interpreta-
tion of FGF expression is consistent with the
multifunctional nature of FGF ligands that induce
Fig. 7. Comparison of mean number of apoptotic cells in contact tissue after different
biomaterial implantation and control
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diverse cellular responses in multiple cell types as
proliferation, differentiation, chemo taxis. Varia-
tions in FGFR expression may in turn lead to func-
tional differences essential for the coordinate regu-
lation of tissue homeostasis and complex processes,
such as wound healing and tissue repair, that in-
volve more than one cell type and demand biologi-
cal responses from individual cells [15]. Szebenyi
[16] mentioned that FGF stimulates the migration
and regeneration of endothelial cells, is promoter
of angiogenesis and stimulates wound healing. Our
findings prove the above mentioned role of FGFs
in regenerative mechanisms of tissues. The inten-
sive expression of FGFR1 in soft tissues around
the HAp implants indicates stimulation of adap-
tive/compensatory mechanisms of regeneration in
connective tissue.
 Inayat-Hussain [17] confirms that the HAp
compounds are not cytotoxic where the mode of
death was primarily via apoptosis. Several studies
demonstrate that cell apoptosis is related to the
size of the HAp particles [18], as well of HAp/
TCP (hydroxyapatite/tricalcium phosphate) ratio in
biphasic ceramic [19]. These results, namely, that
implantation of HAp with lidocaine initiates slightly
less apoptosis as pure HAp are interesting while
the effect of lidocaine on cells is conflicting.
Werdenhausen [20] reported that lidocaine trig-
gers apoptosis, although the underlying mechanisms
still remain unknown. Lei [21] investigated neu-
ronal apoptosis and found that infusion of lidocaine
diminished DNA fragmentation in the penumbra
and the infarct-reducing effects of lidocaine may
be due, in part, to the inhibition of apoptotic cell
death.
CONCLUSIONS
 Within the limits of our study, the following
conclusions can be drawn:
1. The expression of TGF β1 confirms
osteoinductive activity of HAp.
2. Contact soft tissue to HAp showed rich
FGFR1 expression, but weak in controls suggesting
higher plasticity of the connective tissue to implants
in comparison with the supportive tissue.
3. Slightly less apoptosis in samples of HAp
with lidocaine gives evidence of the indistinct influ-
ence of saturated with lidocaine HAp implants on
development of programmed cell death.
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